â??An Open Clinical Trial to Evaluate the Safety & Efficacy of Siddha Sastric Medicines â?? Fixed Regimen in COVID-19 Positive asymptomatic, mild or moderate cases with reference to the Siddha guidelines of COVID-19 management, Ministry of AYUSH, Govt. of India at Agraharam Siddha COVID-19 CARE Centre , Thirupattur District ,Tamilnaduâ??

District Administration0 个研究点目标入组 20 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Adult Male/Female subjects above the age of 18 years
•COVID -19 Positive as determined by RT-PCR
•Willing to provide written/digital informed consent.
•COVID - 19 Positive with no clinical signs
•COVID - 19 Positive with mild symptoms â?? Sneezing, Cough, Sore Throat, Throat Pain, Malaise, Tiredness, Fever, loss of smell, loss of taste
•COVID - 19 Positive with moderate symptoms â?? Fever with cough, breathlessness but respiratory rate <24 per minute and Oxygen saturation > 95% at rest

•Pregnant and Lactating females
•COVID - 19 Positive with Severe symptoms â?? Respiratory distress ( >24 breath per minute), Oxygen saturation < 95% at rest, Respiratory failure, Need of Mechanical Ventilation, Septic shock, Non respiratory organ failure
•Chronic Renal Failure requiring dialysis (eGFR < 30)
•Known cases of uncontrolled Diabetes ( >9% HbA1c)
•Known cases of stage 3 Hypertension ( > 160/100 mmHg)
•Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening
•Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc.
•Subjects taking Steroid treatment and or any kind of immunosuppressive therapy
•Subjects who are participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study.
•Subjects with bleeding disorders and severe anemia (Hb <7 g/dL)

发起方

District Administration